Product Description
Trelagliptin
Trelagliptin, also known as SYR-472, is a long acting dipeptidyl peptidase-4 (DPP-4) inhibitor that is being developed by Takeda for the treatment of type 2 diabetes (T2D). Once-weekly SYR-472 treatment produced clinically and statistically significant improvements in glycaemic control in patients with type 2 diabetes. It was well tolerated and might be a new treatment option for patients with this disease. Trelagliptin (Zafatek(®)) was approved in Japan for the treatment of type 2 diabetes mellitus (T2DM).
Specifications
| Product Name | Trelagliptin |
| CAS NO. | 865759-25-7 |
| MOQ | 1 kg |
| Other Name | Trelagliptin (USAN),Trelagliptin,UNII-Q836OWG55H,SYR 472 |
| Molecular Formular | C18H20FN5O2 |
| Molecular Weight | 357.382 |
| Appearance | White powder |
| Brand | Monad |
| Purity | 0.99 |
| Density | 1.4±0.1 g/cm3 |
| LogP | 1.88 |
| Boiling Point | 519.0±60.0 °C at 760 mmHg |
| Flash Point | 267.7±32.9 °C |
Hot Tags: trelagliptin cas 865759-25-7, China, manufacturers, suppliers, factory, cheap, discount, quotation, low price, free sample


